(hydroxy-2-naphthalenylmethyl)phosphonic acid has been researched along with (2S)-7-hydroxyflavanone in 1 studies
| Studies ((hydroxy-2-naphthalenylmethyl)phosphonic acid) | Trials ((hydroxy-2-naphthalenylmethyl)phosphonic acid) | Recent Studies (post-2010) ((hydroxy-2-naphthalenylmethyl)phosphonic acid) | Studies ((2S)-7-hydroxyflavanone) | Trials ((2S)-7-hydroxyflavanone) | Recent Studies (post-2010) ((2S)-7-hydroxyflavanone) |
|---|---|---|---|---|---|
| 11 | 0 | 5 | 5 | 0 | 1 |
| Protein | Taxonomy | (hydroxy-2-naphthalenylmethyl)phosphonic acid (IC50) | (2S)-7-hydroxyflavanone (IC50) |
|---|---|---|---|
| Proteasome subunit beta type-5 | Homo sapiens (human) | 5.21 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CJ; Geahlen, RL | 1 |
1 review(s) available for (hydroxy-2-naphthalenylmethyl)phosphonic acid and (2S)-7-hydroxyflavanone
| Article | Year |
|---|---|
Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents.
Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Protein-Tyrosine Kinases | 1992 |